-
-
-
-
-
-
-
Sanofi expands AI center in Toronto with $294 million investment
-
-
-
-
-
-
-
Sanofi (SNY) PT Lowered to $55 at Morgan Stanley
-
-
-
-
-
-
-
Sanofi (SNY) Tops Q4 EPS by 69c; offers outlook
-
-
-
-
-
-
-
FDA approves Sanofi's Cablivi for pediatric blood clotting disorder
-
-
-
-
-
-
-
Sanofi wins EU approval for Wayrilz to treat immune thrombocytopenia
-
-
-
-
-
-
-
Valuation in this big pharma stock continues to be attractive: analyst
-
-
-
-
-
-
-
Revvity partners with Sanofi to develop type 1 diabetes screening test
-
412,548 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

